The MYC oncoprotein directly interacts with its chromatin cofactor PNUTS to recruit PP1 phosphatase
Authors:
- Yong WeiYWYong Wei
- Cornelia RedelCRCornelia Redel
- Alexandra AhlnerAAAlexandra Ahlner
- Isak Johansson-ÅkheIJIsak Johansson-Åkhe
- Scott HoulistonSHScott Houliston
- Tristan M G KenneyTKTristan M G Kenney
- Vivian MoradVMVivian Morad
- Shili DuanSDShili Duan
- David W AndrewsDADavid W Andrews
- Björn WallnerBWBjörn Wallner
Open Access
- 4 March 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 50 (6) , 3505-3522
Abstract
Despite MYC dysregulation in most human cancers, strategies to target this potent oncogenic driver remain an urgent unmet need. Recent evidence shows the PP1 phosphatase and its regulatory subunit PNUTS control MYC phosphorylation, chromatin occupancy, and stability, however the molecular basis remains unclear. Here we demonstrate that MYC interacts directly with PNUTS through the MYC homology Box 0 (MB0), a highly conserved region recently shown to be important for MYC oncogenic activity. By NMR we identified a distinct peptide motif within MB0 that interacts with PNUTS residues 1–148, a functional unit, here termed PNUTS amino-terminal domain (PAD). Using NMR spectroscopy we determined the solution structure of PAD, and characterised its MYC-binding patch. Point mutations of residues at the MYC-PNUTS interface significantly weaken their interaction both in vitro and in vivo, leading to elevated MYC phosphorylation. These data demonstrate that the MB0 region of MYC directly interacts with the PAD of PNUTS, which provides new insight into the control mechanisms of MYC as a regulator of gene transcription and a pervasive cancer driver.Keywords
All Related Versions
Funding Information
- Canadian Institutes of Health Research (FRN156167, FDN154328, FDN143312)
- Swedish Cancer Society (20 1276 PjF 01 H)
- Swedish Childhood Cancer Foundation (PR2019-0143, TJ2018-0103)
- Swedish Research Council (2018-04390, 2016-05369)
- Princess Margaret Cancer Centre
- Princess Margaret Cancer Foundation
- Ontario Ministry of Health (1097737)
- Bayer AG
- Boehringer Ingelheim
- Bristol Myers Squibb
- Genentech
- Genome Canada (OGI-196, 875510)
- Janssen
- Merck KGaA
- Pfizer
- Takeda
- Linköping University
- Swedish National Infrastructure for Computing
- National Supercomputer Centre
This publication has 75 references indexed in Scilit:
- Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 bindingNucleic Acids Research, 2012
- A Smoothed Backbone-Dependent Rotamer Library for Proteins Derived from Adaptive Kernel Density Estimates and RegressionsStructure, 2011
- High-throughput production of human proteins for crystallization: The SGC experienceJournal of Structural Biology, 2010
- The extended PP1 toolkit: designed to create specificityTrends in Biochemical Sciences, 2010
- ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acidsNucleic Acids Research, 2010
- TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shiftsJournal of Biomolecular NMR, 2009
- Evaluating protein structures determined by structural genomics consortiaProteins: Structure, Function, and Bioinformatics, 2007
- Cancer therapeutics: Targeting the dark side of MycEuropean Journal of Cancer, 2005
- Evasion of the p53 tumour surveillance network by tumour-derived MYC mutantsNature, 2005
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995